Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma.

Lin L, Hicks D, Xu B, Sigel JE, Bergfeld WF, Montgomery E, Fisher C, Hartke M, Tubbs R, Goldblum JR.

Mod Pathol. 2005 May;18(5):705-9.

2.
3.

Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.

Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, Wennerberg J.

Int J Oncol. 2002 Jan;20(1):45-52.

PMID:
11743641
4.

Cyclin D1 gene expression in human cervical neoplasia.

Nichols GE, Williams ME, Gaffey MJ, Stoler MH.

Mod Pathol. 1996 Apr;9(4):418-25.

PMID:
8729983
5.

Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.

Hui P, Howe JG, Crouch J, Nimmakayalu M, Qumsiyeh MB, Tallini G, Flynn SD, Smith BR.

Leuk Lymphoma. 2003 Aug;44(8):1385-94.

PMID:
12952233
6.

FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.

Dongsong N, Zhou JY.

Mol Biol Rep. 2010 Oct;37(7):3473-80. doi: 10.1007/s11033-009-9939-y. Epub 2009 Dec 5.

PMID:
19967453
7.

Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.

Simpson JF, Quan DE, O'Malley F, Odom-Maryon T, Clarke PE.

Am J Pathol. 1997 Jul;151(1):161-8.

8.

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.

Specht K, Haralambieva E, Bink K, Kremer M, Mandl-Weber S, Koch I, Tomer R, Hofler H, Schuuring E, Kluin PM, Fend F, Quintanilla-Martinez L.

Blood. 2004 Aug 15;104(4):1120-6. Epub 2004 Apr 13.

9.

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.

Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC; Lymphoma/Leukemia Molecular Profiling Project..

Blood. 2005 Dec 15;106(13):4315-21. Epub 2005 Aug 25.

10.

Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.

Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, El-Naggar A, Hong WK, Hittelman WN.

Oncogene. 1998 Nov 5;17(18):2313-22.

11.

Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.

Saito T, Oda Y, Yamamoto H, Kawaguchi K, Tanaka K, Matsuda S, Iwamoto Y, Tsuneyoshi M.

Hum Pathol. 2006 Jun;37(6):689-97.

PMID:
16733209
12.

A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.

Belaud-Rotureau MA, Parrens M, Dubus P, Garroste JC, de Mascarel A, Merlio JP.

Mod Pathol. 2002 May;15(5):517-25.

13.

In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.

Athanasiou E, Kotoula V, Hytiroglou P, Kouidou S, Kaloutsi V, Papadimitriou CS.

Mod Pathol. 2001 Feb;14(2):62-71.

14.
15.

Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.

Greer RO Jr, Said S, Shroyer KR, Marileila VG, Weed SA.

Oral Oncol. 2007 Sep;43(8):735-41. Epub 2006 Nov 17.

PMID:
17113340
16.

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.

Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M.

Mod Pathol. 2006 Jul;19(7):999-1009. Epub 2006 Apr 28.

17.

Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors.

Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB.

Prostate. 1998 May;35(2):95-101.

PMID:
9568672
18.

Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.

Kwon YK, Jun JM, Shin SW, Cho JW, Suh SI.

Int J Oncol. 2005 Jun;26(6):1597-603.

PMID:
15870875
19.

Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile.

Mottolese M, Orlandi G, Sperduti I, Merola R, Buglioni S, Di Benedetto A, Pinnarò P, Perracchio L, Venturo I, Cognetti F, Cianciulli A.

Am J Surg Pathol. 2007 Feb;31(2):247-54.

PMID:
17255770
20.

Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.

Lin BT, Brynes RK, Gelb AB, McCourty A, Amin MB, Medeiros LJ.

Mod Pathol. 1998 Nov;11(11):1075-81.

PMID:
9831205

Supplemental Content

Support Center